BrigidSweeneyBolandMD

Advanced Endoscopic Interventional, Inflammatory Bowel Disease

Associate Professor

Dr. Boland is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
9350 Campus Point Dr
La Jolla, CA 92037
Phone+1 858-657-7423

Fax+1 858-657-7259

UC San Diego Medical Center - HillcrestPost-Doctoral Fellowship, 2014 - 2015
University of California (San Diego) Medical CenterFellowship, Gastroenterology, 2010 - 2013
University of California (San Diego) Medical CenterResidency, Internal Medicine, 2008 - 2010
University of California San Francisco School of MedicineClass of 2008

PubMed

1 citations
Long-Term Outcomes of an Infliximab-First Versus Vedolizumab-First Treatment Strategy in Biologic-Naïve Patients With Ulcerative Colitis.
Austin Haynesworth, Kuan-Hung Yeh, Han Hee Lee, Melissa Kirkpatrick, Brigid S Boland
Alimentary Pharmacology & Therapeutics. 2025-02-01
Tissue-resident memory CD8 T cell diversity is spatiotemporally imprinted.
Miguel Reina-Campos, Alexander Monell, Amir Ferry, Vida Luna, Kitty P Cheung
Nature. 2025-01-22
Vedolizumab Does Not Affect Antibody Secreting Cell Recruitment to the Lactating Mammary Gland of Mothers With Inflammatory Bowel Disease.
Josef Urrete, Taniya Mitra, Brigid S Boland, Kerri Bertrand, Christina Chambers
Inflammatory Bowel Diseases. 2025-01-06

Journal Articles

Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
Leah Katta, Robert Hirten, Shannon Chang, Dana Lukin, Edward V Loftus, David Faleck, Arun Swaminath, William J Sandborn, Sashidhar Varma Sagi, Sunanda Kane, Prianka Ch..., Nature
Comparison of Multiplex Gastrointestinal Pathogen Panel and Conventional Stool Testing for Evaluation of Diarrhea in Patients with Inflammatory Bowel Diseases
Waseem Ahmad, Daniel Bouland, Nghia H Nguyen, David T Pride, Siddharth Singh, Parambir S Dulai, William J Sandborn, Brigid S Boland, Digestive Diseases and Sciences
Cell Trafficking Interference in Inflammatory Bowel Disease: Therapeutic Interventions Based on Basic Pathogenesis Concepts
Parambir S Dulai, William J Sandborn, Brigid S Boland, Derek R Patel, Inflammatory Bowel Diseases
Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
Gursimran Kochhar, Justin Hartke, Sashidhar Varma Sagi, Edward V Loftus, Joseph Meserve, Robert Hirten, David Faleck, Shannon Chang, Dana Lukin, Farhad Peerani, Leah K..., Nature
Join now to see all

Organoids Derived from Gut Stem Cells Reveal Two Distinct Molecular Subtypes of Crohn’s DiseaseSeptember 26th, 2024
Organoids Derived from Gut Stem Cells Reveal Two Distinct Molecular Subtypes of Crohn’s DiseaseSeptember 26th, 2024
Dogs Can Be Protective, Including Against Crohn’s DiseaseJune 2nd, 2022
Join now to see all